Prevention and Treatment of Cancer-Related Infections, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2024-11 · 22 (9) · 617-644
DOI: 10.6004/jnccn.2024.0056 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2024-11. Verfasst von Lindsey Robert Baden und 33 weiteren Autor:innen. Beteiligte Einrichtung: 1Dana-Farber Cancer Institute. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 93-mal zitiert (Crossref) und nennt 302 Literaturangaben.
Abstract (Originalsprache)
There is an increased risk of infection in patients with cancer that results in higher morbidity and mortality. Several risk factors can predispose these patients to infectious complications. Some such factors include immunocompromised states like neutropenia, allogeneic hematopoietic cell transplantation, and graft-versus-host disease, while others include immunosuppressive agents like corticosteroids, purine analogs, monoclonal antibodies, and other emerging cancer therapeutics like CAR T-cell therapy. The NCCN Guidelines for the Prevention and Treatment of Cancer-Related Infections address infection concerns that may be observed in these immunocompromised populations and characterize the major pathogens to which patients with cancer are susceptible, with a focus on the prevention, diagnosis, and treatment of major common and opportunistic infections. This paper highlights 2 recently updated sections of the guidelines, namely, infection concerns related to CAR T-cell therapy and antimicrobial prophylaxis recommendations, including vaccination, in patients at high-risk for infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- 1Dana-Farber Cancer Institute.
- 2Huntsman Cancer Institute at the University of Utah.
- 3Roswell Park Comprehensive Cancer Center.
- 4Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
- 5Moffitt Cancer Center.
- 6Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
Zitieren
APA
Baden, L. R., Swaminathan, S., Almyroudis, N. G., Angarone, M., Baluch, A., Barros, N., Buss, B., Cohen, S., Cooper, B., Chiang, A. D., Boghdadly, Z. E., Gregg, K., Hakim, H., Ho, D., Khawaja, F., Lee, R., Lee, F., Logan, C., Manley, K., …, & Diwan, Z. (2024). Prevention and Treatment of Cancer-Related Infections, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 22(9), 617-644. https://doi.org/10.6004/jnccn.2024.0056
Vancouver
Baden LR, Swaminathan S, Almyroudis NG, Angarone M, Baluch A, Barros N, et al. Prevention and Treatment of Cancer-Related Infections, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2024;22(9):617-644. doi:10.6004/jnccn.2024.0056
BibTeX
@article{Baden2024,
author = {Baden, Lindsey Robert and Swaminathan, Sankar and Almyroudis, Nikolaos G and Angarone, Michael and Baluch, Aliyah and Barros, Nicolas and Buss, Brian and Cohen, Stuart and Cooper, Brenda and Chiang, Augusto Dulanto and Boghdadly, Zeinab El and Gregg, Kevin and Hakim, Hana and Ho, Dora and Khawaja, Fareed and Lee, Rachael and Lee, Francesca and Logan, Cathy and Manley, Kristen and Multani, Ashrit and Pande, Anupam and Pergam, Steven and Pisano, Jennifer and Saullo, Jennifer and Schuster, Mindy and Seo, Susan K and Shoham, Shmuel and Taplitz, Randy and Topal, Jeffrey and Wilson, John W and Zimmer, Andrea and Cassara, Carly J and Kumar, Rashmi and Diwan, Zeenat},
title = {Prevention and Treatment of Cancer-Related Infections, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2024},
volume = {22},
number = {9},
pages = {617--644},
doi = {10.6004/jnccn.2024.0056}
}
EUVIMED